Amundi
ADMA icon

Amundi’s ADMA Biologics ADMA Stock Holding History

Amundi’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$320K Sell
38,182
-13,579
-26% -$124K ﹤0.01% 1824
2026
Q1 		$466K Buy
51,761
+19,985
+63% +$315K ﹤0.01% 1571
2025
Q4 		$580K Sell
31,776
-10,632
-25% -$179K ﹤0.01% 1423
2025
Q3 		$597K Buy
42,408
+3,438
+9% +$58.9K ﹤0.01% 1279
2025
Q2 		$707K Buy
+38,970
New +$795K ﹤0.01% 1282

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Amundi's ADMA Position: Q2 2026 in Review

Amundi reduced its ADMA Biologics (ADMA) stake by 26% in Q2 2026, selling an estimated $124K and leaving 38,182 shares worth $320K. The position accounts for ﹤0.01% of the portfolio, ranked #1824.

Amundi first reported a position in ADMA in Q2 2025 and has held it in 5 quarters since. The position peaked at $707K in Q2 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Amundi held 38,182 shares of ADMA Biologics worth $320K as of Q2 2026.
  • Amundi sold 13,579 ADMA Biologics shares in Q2 2026, an estimated $124K.
  • ADMA Biologics made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1824 holding.
  • Amundi first reported a position in ADMA Biologics in Q2 2025 and has held it in 5 quarters since.
  • Amundi's ADMA Biologics position peaked at $707K in Q2 2025.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.